Roivant Sciences Ltd. (ROIV)
Roivant Sciences Max Pain By Strike
ROIV trades at $11.76, 2.0% below the near-term max pain of $12 expiring Sep 19, 2025 (31 days). Price stability likely with balanced options positioning at this level. Max pain is rising across expirations ($3-$12), reflecting growing call interest at higher strikes. Key magnetic zone at 10 where 2 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Roivant Sciences Max Pain By Expiry
Max pain for ROIV shows an upward trend from 3 to 12, suggesting bullish positioning in longer-dated options. The 95% spread signals divergent expectations across timeframes. Most levels below 11.76 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 12 | 0.24 (2.04%) |
| Oct 17, 2025 | 11 | -0.76 (-6.46%) |
| Nov 21, 2025 | 10 | -1.76 (-14.97%) |
| Jan 16, 2026 | 11 | -0.76 (-6.46%) |
| Feb 20, 2026 | 3 | -8.76 (-74.49%) |
| Jan 15, 2027 | 10 | -1.76 (-14.97%) |